Press release
Heart Pump Devices Market is expected to rise at a CAGR of 5.74% by 2032, estimates DelveInsight
The Heart Pump Devices market, valued at USD 4.44 billion in 2023, is projected to grow at a CAGR of 5.74% from 2024 to 2030, reaching USD 6.20 billion by 2030. Rising cases of cardiovascular diseases (CVDs), driven by lifestyle changes, smoking, sedentary habits, alcohol consumption, and obesity, are fueling market growth. Public health campaigns promoting awareness and regular check-ups have further boosted the adoption of cardiovascular imaging and early disease management. In addition, continuous R&D investments, product innovations, collaborations, and regulatory approvals by leading players are expected to keep the market dynamic and competitive throughout the forecast period.DelveInsight's Heart Pump Devices Market Insights report provides the current and forecast market analysis, individual leading Heart Pump Devices companies' market shares, challenges, Heart Pump Devices market drivers, barriers, and trends, and key Heart Pump Devices companies in the market.
Request for a sample page report @ https://www.delveinsight.com/report-store/heart-pump-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Heart Pump Devices Market Report
The Heart Pump Devices market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Heart Pump Devices market during the forecast period.
Notable Heart Pump Devices companies such as General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., Implicity, Mindray Medical International Limited, Hill-Rom Holdings, Inc., OSI System Inc., VUNO Inc., AliveCor, and several others are currently operating in the Heart Pump Devices market.
In December 2024, the FDA granted premarket approval (PMA) to Johnson & Johnson MedTech's Impella 5.5 and Impella CP with SmartAssist heart pumps for treating pediatric patients with acute decompensated heart failure and cardiogenic shock.
In February 2022, AliveCor, a leading innovator in FDA-cleared personal ECG solutions, launched the KardiaMobile Card, the thinnest and most convenient personal ECG device available.
In January 2022, Royal Philips, a global health technology leader, introduced the industry's first comprehensive at-home 12-lead ECG solution, specifically designed to support decentralized clinical trials.
To read more about the latest highlights related to the Heart Pump Devices market, get a snapshot of the key highlights entailed in the Global Heart Pump Devices Market Report https://www.delveinsight.com/sample-request/heart-pump-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Heart Pump Devices Overview
Heart Pump Devices are advanced medical technologies designed to support or replace the natural pumping function of the heart in patients with severe cardiac conditions such as heart failure, cardiogenic shock, and other circulatory disorders. These devices play a critical role in improving patient survival, stabilizing hemodynamics, and serving as a bridge to recovery, heart transplantation, or long-term therapy.
The market is being driven by the rising prevalence of cardiovascular diseases worldwide, fueled by factors such as sedentary lifestyles, obesity, smoking, and aging populations. Continuous technological advancements, including portable and wearable monitoring systems, AI-enabled diagnostic tools, and minimally invasive devices, are further accelerating adoption.
Key product categories include Resting ECG Systems, Stress ECG Systems, Holter Monitors, and Cardiopulmonary Stress Testing Systems, with modality types spanning portable, stationary, and wearable devices. End-users range from hospitals and ambulatory surgical centers to home-based patients, reflecting the growing trend toward remote and continuous monitoring.
Overall, the Heart Pump Devices market is poised for sustained growth, supported by increasing healthcare awareness, early diagnosis initiatives, and continuous R&D investments from leading medical technology players.
Heart Pump Devices Market Insights
Heart Pump Devices Market by Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, and Cardiopulmonary Stress Testing Systems), Type (Single Lead, 3-6 Lead, and 12-Lead), Modality (Portable, Stationary, and Wearables), End-Users (Hospitals, Home-based Users, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Within the product category, Holter monitors are expected to capture a significant share of the Heart Pump Devices market in 2023. These devices are widely used for detecting abnormal cardiac activity and play a key role in both diagnosis and maintaining normal heart function. Traditionally prevalent in hospital settings, Holter monitors have been the preferred choice for electrocardiogram (ECG) monitoring.
Advancements in portable and compact Holter ECGs are driving higher adoption, particularly in home healthcare. Unlike traditional ECG tests, portable Holter devices provide continuous monitoring of heart activity for 24 hours or longer, offering greater diagnostic accuracy and convenience. Their ability to track chronic conditions such as atrial fibrillation and evaluate long-term treatment effectiveness makes them vital tools in personalized patient care.
Additionally, Holter monitors allow patients to maintain their daily routines during monitoring, enhancing comfort and compliance compared to inpatient ECG testing. These benefits collectively contribute to the strong market positioning of Holter monitors.
To know more about why North America is leading the market growth in the Heart Pump Devices market, get a snapshot of the Heart Pump Devices Market Outlook https://www.delveinsight.com/report-store/heart-pump-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Heart Pump Devices Market Dynamics
According to the recent data provided by the British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, live with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021.
Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, the most commonly diagnosed worldwide, affects an estimated 200 million people globally. Approximately 110 million men and 80 million women are affected. Additionally, around 56 million women and 45 million men are stroke survivors. It's estimated that at least 13 million people worldwide live with congenital heart disease, with potentially millions more undiagnosed.
The above-mentioned facts state the dire need for measures to address the rising disease burden of CVDs across the globe. Indications such as atherosclerosis, and arrhythmias can affect the quality of life of patients. Furthermore, in many cases, the severity of CVDs can be reduced by regular monitoring of cardiac rhythms and activities. This can be achieved by deploying Heart Pump Devices. These devices enable healthcare providers as well as patients to diagnose the defects of the conduction system as per the need, thereby helping in the improvement of disease prognosis as well helping in early disease diagnosis. Therefore, the global Heart Pump Devices market is expected to witness remarkable growth during the forecast period.
Additionally, technological advancements play a pivotal role in accelerating the market growth of Heart Pump Devices by enhancing diagnostic accuracy, speed, and patient outcomes. For instance, in June 2021, South Korean AI developer VUNO Inc. announced that the Korean Ministry of Food and Drug Safety (KFDA) had designated its AI-based ECG analysis software, VUNO Med®-DeepECGTM, as the ministry's 16th Breakthrough Device. Utilizing deep learning, the software analyzed ECG data to detect heart failure, myocardial infarction, and arrhythmia.
Heart Pump Devices Market Drivers:
Rising prevalence of cardiovascular diseases and its risk factors, technological advancement in product development
Growing awareness regarding cardiovascular diseases across the globe
Get a sneak peek at the Heart Pump Devices market dynamics @ https://www.delveinsight.com/sample-request/heart-pump-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Scope of the Heart Pump Devices Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Heart Pump Devices Companies: General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., Implicity, Mindray Medical International Limited, Hill-Rom Holdings, Inc., OSI System Inc., VUNO Inc., AliveCor, and others.
Which MedTech key players in the Heart Pump Devices market are set to emerge as the trendsetter, explore @ Heart Pump Devices Companies https://www.delveinsight.com/report-store/heart-pump-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Leber's Hereditary Optic Neuropathy Market
https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Info:
Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Pump Devices Market is expected to rise at a CAGR of 5.74% by 2032, estimates DelveInsight here
News-ID: 4152636 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…